EBOS Group Limited (ASX:EBO – Get Free Report) insider Julie Tay purchased 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were purchased at an average price of A$26.00 per share, for a total transaction of A$52,000.00.
EBOS Group Stock Performance
The firm has a market capitalization of $8.20 billion, a price-to-earnings ratio of 27.51 and a beta of 0.26. The company has a debt-to-equity ratio of 66.89, a quick ratio of 0.76 and a current ratio of 0.95.
EBOS Group Cuts Dividend
The business also recently announced a Final dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Tuesday, September 23rd were paid a $0.492 dividend. This represents a yield of 168.0%. The ex-dividend date was Wednesday, September 3rd. EBOS Group’s payout ratio is presently 72.14%.
EBOS Group Company Profile
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
Featured Stories
- Five stocks we like better than EBOS Group
- Dividend Payout Ratio Calculator
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Compound Interest and Why It Matters When Investing
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- What is the Nasdaq? Complete Overview with History
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Receive News & Ratings for EBOS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EBOS Group and related companies with MarketBeat.com's FREE daily email newsletter.
